Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Referenceopen allclose all

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
1976
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Doses:
10000 mg/kg bw
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 7 d
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 10 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: short observation period: 7 d
Mortality:
No mortality
Clinical signs:
other: Slight apathy; faeces, urine and skin systemically stained orange
Gross pathology:
Splenomegaly
Interpretation of results:
GHS criteria not met
Conclusions:
The LD50 (acute, oral) for rats was determined to be >10000 mg/kg bw.
Executive summary:

The LD50 (acute, oral) for rats was determined to be >10000 mg/kg bw.

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
1979
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no
Species:
rat
Strain:
Sprague-Dawley
Sex:
not specified
Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 d
Sex:
not specified
Dose descriptor:
LD50
Effect level:
3 840 mg/kg bw
Based on:
test mat.
Interpretation of results:
GHS criteria not met
Conclusions:
The LD50 (acute, oral) for rats was determined to be 3840 mg/kg bw.
Executive summary:

The LD50 (acute, oral) for rats was determined to be 3840 mg/kg bw.

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
1978
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
documentation insufficient for assessment
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no
Species:
rat
Strain:
Sprague-Dawley
Sex:
not specified
Route of administration:
oral: gavage
Vehicle:
CMC (carboxymethyl cellulose)
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 46.4 and 50.0% (w/w)
- Amount of vehicle (if gavage): 0.5% (w/w)
- Justification for choice of vehicle: dispersant

MAXIMUM DOSE VOLUME APPLIED: 10000 mg/kg bw
Doses:
6800 and 10000 mg/kg
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 d
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 6 800 - < 10 000 mg/kg bw
Based on:
test mat.
Mortality:
All mortalities occured on day 0 (application day)
Clinical signs:
other: Impairment of general state of health, staggering, diarrhoea, orange stained faeces and urine
Gross pathology:
acute heart dilatation, acute congestion of vessels
Interpretation of results:
GHS criteria not met
Conclusions:
The LD50 (acute, oral) for rats was determined to be >6800 mg/kg bw.
Executive summary:

The LD50 (acute, oral) for rats was determined to be >6800 mg/kg bw.

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
11 August 1998 to 25 August 1998
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: HARLAN WINKLEMANN, Gartenstr. 27, 33178 Borchen, SPF breeding colony
- Age at study initiation: 6 - 10 weeeks
- Weight at study initiation: Males - 190g, Females - 172g
- Fasting period before study: 16 hours before
- Housing: Fully air-conditioned rooms in macrolon cages (type 4) on soft wood granulate in groups of 5
- Diet (e.g. ad libitum): ssniff R/M-H (V 1534), ad libitum
- Water (e.g. ad libitum): tap water in plastic bottles, ad libitum
- Acclimation period: seven days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 50
- Photoperiod (hrs dark / hrs light): 12 hours dark/ 12 hours light

Route of administration:
oral: gavage
Vehicle:
other: sesame oil (Oleum sesami DAB 10)
Details on oral exposure:
The acute oral toxicity of T-9601 was tested only at a dose level of 2000 mg/kg body weight.
The animals received the compound as a 20 % suspension in sesame oil (Oleum sesami DAB 10), the administration volume being 10 ml/kg body weight.
If no compound-related mortality is produced in this limit test according to the guidelines no full study has to be carried out.
Doses:
2000 mg/kg body weight
No. of animals per sex per dose:
Males - 5
Females - 5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations twice daily (in the morning and in the afternoon), on weekends and public holidays only once. uring this time animals were weighed weekly.
- Necropsy of survivors performed: yes
Statistics:
No data
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
Male: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0 Female: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Clinical signs:
other: No clinical signs of toxicity related to dose levels where noted during the study.
Gross pathology:
Effects on organs: No macroscopic visible changes were found.
Other findings:
Orange discoloured feces in all animals after 2 days of administration
Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Based on the results obtained in this study the median lethal dose value (LD50) of the substance for the male & female rat is greater than 2000 mg/kg body weight.
Executive summary:

Study data conducted to EEC-Guideline B.1 of the Directive 92/68/EEC and OECD Guidleines for Testing of Chemicals 401 in compliance with GLP.

The median lethal dose value (LD50) of the substance for the male & female rat is greater than 2000 mg/kg body weight. The substance is not classified as harmful by oral exposure.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Quality of whole database:
The lowest LD50 value in a weight-of-evidence approach was determined at >2000 mg/kg bw for one of the source substances. Therefore, the classification criteria for CLP are not met (LD50 oral >2000 mg/kg bw). No difference in acute toxicity is assumed for the target substance.

Additional information

Justification for classification or non-classification